RGNX
Regenxbio Inc
Price:  
8.16 
USD
Volume:  
742,903.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGNX Relative Valuation

-1236.5%
Upside

As of 2025-07-19, the Relative Valuation of Regenxbio Inc (RGNX) is (92.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.16 USD, the upside of Regenxbio Inc based on Relative Valuation is -1236.5%.

The range of the Relative Valuation is (77.90) - (93.62) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.2x - 29.8x 26.7x
Forward P/E multiples 24.8x - 42.0x 32.3x
Fair Price (77.90) - (93.62) (92.74)
Upside -1054.7% - -1247.3% -1236.5%
8.16 USD
Stock Price
(92.74) USD
Fair Price

RGNX Relative Valuation - Historical P/E Data

Date P/E
2025-07-16 -2.70
2025-07-15 -2.62
2025-07-14 -2.77
2025-07-11 -2.76
2025-07-10 -2.88
2025-07-09 -2.92
2025-07-08 -2.78
2025-07-07 -2.68
2025-07-03 -2.78
2025-07-02 -2.74
2025-07-01 -2.62
2025-06-30 -2.61
2025-06-27 -2.67
2025-06-26 -2.78
2025-06-25 -2.72
2025-06-24 -2.72
2025-06-23 -2.50
2025-06-20 -2.68
2025-06-18 -2.73
2025-06-17 -2.75
2025-06-16 -2.91
2025-06-13 -2.95
2025-06-12 -3.24
2025-06-11 -3.24
2025-06-10 -3.12
2025-06-09 -3.03
2025-06-06 -3.06
2025-06-05 -2.66
2025-06-04 -3.21
2025-06-03 -3.22
2025-06-02 -3.29
2025-05-30 -2.82
2025-05-29 -2.85
2025-05-28 -2.72
2025-05-27 -2.89
2025-05-23 -3.09
2025-05-22 -3.14
2025-05-21 -3.07
2025-05-20 -3.18
2025-05-19 -3.11
2025-05-16 -2.83
2025-05-15 -2.75
2025-05-14 -2.65
2025-05-13 -2.60
2025-05-12 -2.54
2025-05-09 -2.39
2025-05-08 -2.27
2025-05-07 -2.30
2025-05-06 -2.52
2025-05-05 -3.10